Astiva Health Inc. CEO Featured Podcast Guest, Talks Commitment to Help Patients Enjoy ‘Active, Healthy and Meaningful’ Lives

March 4, 2024 09:35:00

  • In addition to providing full medical-care prescription drugs, Astiva focuses on providing rich supplemental benefits to enrollees
  • CEO explains that “effective healthcare hinges largely on patient involvement”
  • Astiva’s recent expansion is a crucial step in extending invaluable benefits and commitment to quality healthcare to a growing, diverse population

Astiva Health CEO Dr. Tri Nguyen was the featured guest in a recent Bell2Bell Podcast release (https://ibn.fm/0Rufk). During the podcast, Nguyen talked provided an in-depth look at how Astiva Health is reshaping healthcare delivery, including an overview of the company’s commitment to patient involvement in healthcare and highlights the company’s innovative strategies in offering comprehensive care.

During the interview, Nguyen chatted with Bell2Bell about the history of the company, noting that it it started operations on Jan. 1, 2021, in Orange County and San Diego with recent expansions into Los Angeles, San Bernardino, and Riverside. “The name Astiva blends ‘ast’ — an old English, Nordic, and German word meaning ‘love’ or ‘enjoy’ — with ‘viva,’ meaning ‘life,’” explained Nguyen.

“[The name] encapsulates our philosophy of loving life, which is central to our healthcare approach,” he continued. “So Astiva, other than providing full medical-care prescription drugs, we also focus on providing a very rich supplemental benefits to our enrollees and getting them involved, participate and aim for an active, healthy and meaningful life.”

Nguyen’s journey to heading up Astiva, the growing Medicare Advantage prescription drug health plan, includes more than two decades of medical practice and an association with esteemed institutions such as Stanford Medical School, UC Davis, and UC San Diego.

“In my over 25 years of medical practice, I’ve realized that effective healthcare hinges largely on patient involvement,” he observed. “It’s about active participation rather than passivity. At Astiva, we emphasize this in our care approach, leading to healthier lives and reduced medical costs. Leveraging technology and efficient operations as a startup, we’ve been able to reinvest savings into rich supplemental benefits for our members.”

Nguyen explained that active participation by enrollees involves exercising, following diet guidelines, and taking medication as prescribed, and when individuals did these things, they enjoyed healthier lifestyles and reduced medical costs, which are primary objective for Astiva.

During his remarks, Nguyen said that Astiva’s recent expansion is a crucial step in extending these benefits and this commitment to quality healthcare to a growing, diverse population. However, Nguyen noted that “the expansion is not just about growth — it’s about deepening our impact in these communities and enhancing our ability to meet the diverse healthcare needs of more people.”

Astiva Health is dedicated to innovative health plans that meet the unique requirements of its members, emphasizing a culturally responsive healthcare model and serving underserved populations. This not only addresses critical societal needs but positions Astiva to capitalize on significant market growth potential. Astiva Health’s goal is to foster lasting relationships and improve the overall well-being of the communities it serves.

For more information, visit the company’s website at www.AstivaHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to Astiva Health are available in the company’s newsroom at https://ibn.fm/Astiva

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN